Clinical Lab Reimbursement Experts Discuss PAMA Pressure and Leaving Money on the Table
Attorney Danielle Tangorre and TELCOR’s Darla Wanitschke answered questions during webinar
Attorney Danielle Tangorre and TELCOR’s Darla Wanitschke answered questions during webinar
The $14.6 billion bust by federal prosecutors shows gaps that every laboratory should monitor
Learn how CLIA could be used as a blueprint to regulate emerging technologies in an effective and dynamic way
The $100 million deal will take advantage of LEX VELO technology to detect influenza and SARS-CoV-2
Washington State’s Department of Health details how its medical testing site program meets federal standards
The legal strategy of the ACLA—and some political luck—prevailed in the lawsuit against LDT oversight
Two OIG advisory opinions guide laboratories that want to work with pharma or medical device companies on expanded testing
The majority of Labcorp’s revenue growth in the first quarter came from clinical lab acquisitions
We explain what ‘tokens’ are, as well as what ‘GPT’ really means
Clinical lab billing teams face an overwhelming number of challenges if revenue cycle strategies fall short
UPMC pathology leader discusses steps the lab takes to combat evolving cyber threats